{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:11:09Z","timestamp":1764936669494,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ajp.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T13:46:32Z","timestamp":1377179192000},"page":"544-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The efficacy of atomoxetine as adjunctive treatment for co-morbid substance use disorders and externalizing symptoms"],"prefix":"10.1016","volume":"6","author":[{"given":"Vivek","family":"Benegal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janardhanan C.","family":"Narayanaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam P.","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaskar","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thennarasu","family":"Kandavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muralidharan","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl.","key":"10.1016\/j.ajp.2013.07.007_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S109285290002602X","article-title":"Non-stimulant trials of adult ADHD","volume":"12","author":"Adler","year":"2007","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-7610.2004.00214.x","article-title":"Young adult follow-up of hyperactive children: antisocial activities and drug use","volume":"45","author":"Barkley","year":"2004","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"7","key":"10.1016\/j.ajp.2013.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1530-0277.1999.tb04269.x","article-title":"What is inherited in the predisposition toward alcoholism? A proposed model","volume":"23","author":"Begleiter","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.ajp.2013.07.007_bib0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-3223(97)00406-X","article-title":"Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?","volume":"44","author":"Biederman","year":"1998","journal-title":"Biol. Psychiatry"},{"year":"2007","series-title":"Atomoxetine Alleviates Executive Function Impairments in Adults with ADHD","author":"Brown","key":"10.1016\/j.ajp.2013.07.007_bib0025"},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-440X(93)90050-E","article-title":"History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers","volume":"34","author":"Carroll","year":"1993","journal-title":"Compr. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2013.07.007_bib0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.biopsych.2007.03.003","article-title":"Atomoxetine improved response inhibition in adults with attention deficit\/hyperactivity disorder","volume":"62","author":"Chamberlain","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2013.07.007_bib0040","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/sj.npp.1301315","article-title":"Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning","volume":"32","author":"Davis","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ajp.2013.07.007_bib0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archpsyc.65.3.310","article-title":"Using dimensional models of externalizing psychopathology to aid in gene identification","volume":"65","author":"Dick","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users","volume":"67","author":"Heil","year":"2002","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.ajp.2013.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/01.ALC.0000090143.00703.07","article-title":"Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor)","volume":"27","author":"Johann","year":"2003","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.ajp.2013.07.007_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10550490050172191","article-title":"Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population","volume":"9","author":"Johnson","year":"2000","journal-title":"Am. J. Addict."},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0033291704002892","article-title":"The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population","volume":"35","author":"Kessler","year":"2005","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15288\/jsad.2009.70.169","article-title":"Childhood ADHD and conduct disorder as independent predictors of male alcohol dependence at age 40","volume":"70","author":"Knop","year":"2009","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"1","key":"10.1016\/j.ajp.2013.07.007_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/15504260802628767","article-title":"Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial","volume":"5","author":"Levin","year":"2009","journal-title":"J. Dual Diagn."},{"issue":"2","key":"10.1016\/j.ajp.2013.07.007_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","article-title":"Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies","volume":"53","author":"Michelson","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2013.07.007_bib0085","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","article-title":"Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study","volume":"108","author":"Michelson","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ajp.2013.07.007_bib0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/alcalc\/agn014","article-title":"Comorbidity of alcohol and substance dependence with attention-deficit\/hyperactivity disorder (ADHD)","volume":"43","author":"Ohlmeier","year":"2008","journal-title":"Alcohol Alcohol."},{"issue":"3","key":"10.1016\/j.ajp.2013.07.007_bib0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","article-title":"Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence","volume":"10","author":"Schubiner","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2013.07.007_bib0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4088\/JCP.v61n0402","article-title":"Prevalence of attention-deficit\/hyperactivity disorder and conduct disorder among substance abusers","volume":"61","author":"Schubiner","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2013.07.007_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/0019-5545.37319","article-title":"Cognitive deficits in children of alcoholics: at risk before the first sip!","volume":"49","author":"Silva","year":"2007","journal-title":"Indian J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2013.07.007_bib0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/ajp.155.5.693","article-title":"Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder","volume":"155","author":"Spencer","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.07.007_bib0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1749-6632.2001.tb05783.x","article-title":"Attention deficit\/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations","volume":"931","author":"Sullivan","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ajp.2013.07.007_bib0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.drugalcdep.2007.10.020","article-title":"Atomoxetine for treatment of marijuana dependence: a report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study","volume":"94","author":"Tirado","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.ajp.2013.07.007_bib0130","first-page":"603","article-title":"Atomoxetine","volume":"43","author":"Unni","year":"2006","journal-title":"Indian Pediatr."},{"issue":"8","key":"10.1016\/j.ajp.2013.07.007_bib0135","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"year":"1992","series-title":"The ICD-10 classification of mental and behavioral disorders; clinical description and diagnostic guidelines","author":"WHO","key":"10.1016\/j.ajp.2013.07.007_bib0140"},{"issue":"3","key":"10.1016\/j.ajp.2013.07.007_bib0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"WHO","year":"1998","journal-title":"Psychol. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.ajp.2013.07.007_bib0150","first-page":"38","article-title":"Impact of ADHD and its treatment on substance abuse in adults","volume":"65","author":"Wilens","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.ajp.2013.07.007_bib0155","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1185\/03007995.2011.628648","article-title":"Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine","volume":"27","author":"Wilens","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"issue":"1\u20132","key":"10.1016\/j.ajp.2013.07.007_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2008.02.009","article-title":"Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders","volume":"96","author":"Wilens","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.ajp.2013.07.007_bib0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00005053-199708000-00001","article-title":"Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders","volume":"185","author":"Wilens","year":"1997","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.ajp.2013.07.007_bib0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajp.2013.07.007_bib0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/cap.2005.15.751","article-title":"Attention-deficit\/hyperactivity disorder and early-onset substance use disorders","volume":"15","author":"Wilson","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201813001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201813001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:23:42Z","timestamp":1761755022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201813001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1876201813001962"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2013.07.007","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of atomoxetine as adjunctive treatment for co-morbid substance use disorders and externalizing symptoms","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}